DOI:
10.1055/s-00000011
DMW - Deutsche Medizinische Wochenschrift
LinksClose Window
References
Fowler NH, Davis RE, Rawal S. et al.
Safety and activity of lenalidomide and rituximab in untreated indolent lymphoma: an open-label, phase 2 trial.
Lancet Oncol 2014;
15: 1311-1318
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.